Loading clinical trials...
Loading clinical trials...
Timely Acquirement of 12-lead Electrocardiography Using Patchy-type Wireless Device Among Patient With Chest Pain in Emergency Departement
In this study, the investigators compare timely acquirement of 12-lead ECG using patchy-type wireless versus using standard 12-lead ECG system among patient with chest pain in ED. The purpose of this study is to determine the difference of timely acquirement of 12-lead ECG using two different systems and the difference of hospital delay in ED between two groups. The participants were randomly divided into 2 groups: one performing an ECG examination using the standard 12-lead ECG and the other using the patch-type mobile 12-lead ECG.The 12-lead ECG will be taken 2 times serially in every 15 minutes.
1. research background Electrocardiography (ECG) is the most important diagnostic tool for rapid detection of acute coronary syndrome, and should be performed and interpreted promptly on appearance of symptoms. Early detection of ST-elevation myocardial infarction (STEMI) on a 12-lead ECG, within 10 minutes after the first medical contact before hospitalization not only minimizes the time taken for diagnosis and reperfusion therapy but also increases the chances of patient survival and preservation of myocardial function. However, it is challenging to perform a 12-lead ECG promptly using the standard 12-lead ECG system for several reasons. First, it is difficult to identify the landmarks for the 10-electrode configuration of the standard ECG. Second, electrodes on the extremities often cause artifacts due to body and muscle movements. Moreover, most of the standard 12-lead ECG systems have cables connected to the precordial and limb leads, which frequently get entangled and disorganized, and can be difficult to manage.Most importantly, its accuracy is dependent on the operators' experience; not just that of the nurses or emergency medical technicians, but also of cardiologists.These difficulties might increase the time taken to perform an ECG especially in pre-hospital situations. 2. Objective The purpose of this study is to determine the difference of timely acquirement of 12-lead ECG using two different systems and the difference of hospital delay in ED between two groups. 3. Design : Randomized controlled trial 4. Setting : ED at the Samsung medical center 5. Enrollment : 36 patients who visited the ED with chest pain 6. Intervention Standard 12-lead ECG will be performed at the time of visiting ED to the participants with chest pain. ED physicians will prescribe to perform second and third 12-lead ECG in every 15 minutes. 1. Control group : Second and third 12 lead ECG will be taken using standard 12-lead ECG device as a doctor's order. 2. Study group :Second and third 12 lead ECG will be taken using patchy-type 12-lead ECG device as a doctor's order. 7\. scoring To measure, interval from the anticipated time to take 12-lead ECG to the time actually performed will be measured. The duration from the anticipated time to the time of verification by physician will be also measured. 8\. study period The experiment ends when patient who agreed to participate in the study discharged the ED.
Age
19 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Samsung Medical Center
Seoul, Gangnam, South Korea
Start Date
July 30, 2019
Primary Completion Date
October 8, 2019
Completion Date
December 16, 2019
Last Updated
October 23, 2020
36
ACTUAL participants
patchy-type wireless 12-lead ECG
DEVICE
Lead Sponsor
Samsung Medical Center
NCT06718374
NCT06669884
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06255769